N. Scott Fine - Feb 7, 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role: Chief Executive Officer, Director
Signature: /s/ N. Scott Fine
Stock symbol: CYTH
Transactions as of: Feb 7, 2022
Transactions value $: $36,996
Form type: 4
Date filed: 2/7/2022, 02:50 PM
Previous filing: Jan 19, 2022
Next filing: Mar 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTH	Common Stock	Purchase	$37K	+10.3K	+7.67%	$3.58	145K	Feb 7, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.50 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.

Content

The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.50 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.